USANA Health Sciences, Inc. (USNA)
NYSE: USNA · Real-Time Price · USD
15.27
-0.19 (-1.23%)
Oct 14, 2026, 4:00 PM EDT - Market closed
USANA Health Sciences Ratios and Metrics
Market cap in millions USD. Fiscal year is February - January.
Millions USD. Fiscal year is Feb - Jan.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Jan '26 Jan 3, 2026 | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
| 282 | 355 | 680 | 1,025 | 1,022 | 1,970 | |
Market Cap Growth | -24.78% | -47.76% | -33.66% | 0.35% | -48.12% | 21.43% |
Enterprise Value | 114 | 264 | 315 | 718 | 775 | 1,721 |
Last Close Price | 15.27 | 19.44 | 35.69 | 53.60 | 53.20 | 101.20 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Jan '26 Jan 3, 2026 | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
PE Ratio | - | 33.03 | 16.18 | 16.07 | 14.73 | 16.91 |
Forward PE | 14.97 | 11.17 | 14.31 | 19.85 | 17.05 | 19.17 |
PS Ratio | 0.31 | 0.38 | 0.80 | 1.11 | 1.02 | 1.66 |
PB Ratio | 0.54 | 0.61 | 1.16 | 2.06 | 2.35 | 4.99 |
P/TBV Ratio | 0.96 | 1.36 | 2.88 | 2.28 | 2.66 | 5.68 |
P/FCF Ratio | 17.71 | 41.68 | 13.36 | 18.26 | 10.93 | 18.16 |
P/OCF Ratio | 10.18 | 15.90 | 11.15 | 14.52 | 9.83 | 16.25 |
PEG Ratio | 1.25 | 0.93 | 1.19 | 1.65 | 1.06 | 1.06 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Jan '26 Jan 3, 2026 | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 0.12 | 0.28 | 0.37 | 0.78 | 0.78 | 1.45 |
EV/EBITDA Ratio | 1.54 | 3.16 | 3.54 | 6.79 | 6.40 | 9.39 |
EV/EBIT Ratio | 2.74 | 5.18 | 4.23 | 7.72 | 7.20 | 10.11 |
EV/FCF Ratio | 7.13 | 30.91 | 6.19 | 12.79 | 8.29 | 15.87 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Jan '26 Jan 3, 2026 | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | - | 0.06 | 0.07 | 0.03 | 0.03 | 0.04 |
Debt / EBITDA Ratio | - | 0.35 | 0.40 | 0.12 | 0.11 | 0.09 |
Debt / FCF Ratio | - | 3.75 | 0.77 | 0.24 | 0.16 | 0.16 |
Net Debt / Equity Ratio | -0.29 | -0.22 | -0.24 | -0.64 | -0.63 | -0.56 |
Net Debt / EBITDA Ratio | -2.28 | -1.51 | -1.60 | -3.00 | -2.26 | -1.22 |
Net Debt / FCF Ratio | -10.58 | -14.83 | -2.80 | -5.65 | -2.93 | -2.05 |
Asset Turnover | 1.27 | 1.24 | 1.24 | 1.50 | 1.70 | 1.95 |
Inventory Turnover | 2.43 | 2.33 | 2.46 | 2.75 | 2.34 | 2.31 |
Quick Ratio | 1.63 | 1.30 | 1.36 | 2.84 | 2.06 | 1.54 |
Current Ratio | 2.66 | 2.24 | 2.00 | 3.52 | 2.67 | 2.27 |
Return on Equity (ROE) | -5.06% | 1.96% | 7.76% | 13.69% | 16.72% | 27.85% |
Return on Assets (ROA) | 3.61% | 4.26% | 6.75% | 9.46% | 11.46% | 17.46% |
Return on Invested Capital (ROIC) | -112.80% | 3.11% | 13.17% | 34.02% | 41.24% | 71.77% |
Return on Capital Employed (ROCE) | 6.90% | 8.30% | 12.30% | 18.10% | 23.80% | 40.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Jan '26 Jan 3, 2026 | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Earnings Yield | -7.86% | 3.03% | 6.18% | 6.22% | 6.79% | 5.92% |
FCF Yield | 5.65% | 2.40% | 7.49% | 5.48% | 9.15% | 5.51% |
Buyback Yield / Dilution | 3.10% | 3.07% | 0.95% | -0.18% | 5.08% | 4.29% |